United Therapeutics

YTD

ALL

Trade United Therapeutics 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About UTHR

United Therapeutics Corp. is a biotechnology company, which engages in the development and commercialization of products for patients with chronic and life-threatening conditions. Its products include Adcirca, Orenitram, Remodulin, TYVASO, and Unituxin.

CEO

Martine A. Rothblatt

CEOMartine A. Rothblatt

Employees

1,305

Employees1,305

Headquarters

Silver Spring, Maryland

HeadquartersSilver Spring, Maryland

Founded

1996

Founded1996

Employees

1,305

Employees1,305

UTHR Key Statistics

Market cap

14.35B

Market cap14.35B

Price-Earnings ratio

12.72

Price-Earnings ratio12.72

Dividend yield

—

Dividend yield—

Average volume

473.50K

Average volume473.50K

High today

$320.48

High today$320.48

Low today

$314.27

Low today$314.27

Open price

$320.18

Open price$320.18

Volume

881.75K

Volume881.75K

52 Week high

$417.82

52 Week high$417.82

52 Week low

$266.98

52 Week low$266.98

Analyst ratings

60%

of 15 ratings

Buy

60%

Hold

40%

Sell

People also own

Based on the portfolios of people who own UTHR. This list is generated using Robinhood data, and it’s not a recommendation.

Vertex Pharmaceuticals

Exelixis

Sprouts Farmers Market

VeriSign

Novo Nordisk

Gilead Sciences